← Back to Search

Financial Incentives for Opioid Use Disorder

N/A
Recruiting
Research Sponsored by Rowan University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Participants at least 18 years of age
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3-months
Awards & highlights

Study Summary

This trial is designed to increase the effectiveness of an existing emergency department "bridge" program for opioid use disorder by adding contingency management to the program.

Who is the study for?
This trial is for adults over 18 with Opioid Use Disorder who are new to the Bridge program at Cooper University ED and have a clinic appointment within a week. They must be in good health, not pregnant or breastfeeding, and able to give informed consent. Those with severe psychiatric conditions or on other opioid treatments can't join.Check my eligibility
What is being tested?
The study tests if financial rewards (Contingency Management) help patients start and stick to treatment with buprenorphine + naloxone for Opioid Use Disorder in an emergency department setting compared to standard care without incentives.See study design
What are the potential side effects?
While the trial focuses on Contingency Management rather than medication side effects, buprenorphine + naloxone may cause withdrawal symptoms, nausea, headache, dizziness, fatigue among others.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3-months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3-months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Attendance at first scheduled clinic appointment
Percentage of sessions where buprenorphine positive urine results was recorded
Percentage of sessions where opioid free urine results were recorded
+1 more
Secondary outcome measures
Delay discounting as a correlate of opioid-free urine test results and buprenorphine-positive results
Neurological Soft Signs correlate with treatment success
Opioid demand as a correlate of opioid-free urine test results and buprenorphine-positive results
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Contingency ManagementExperimental Treatment1 Intervention
Participants in this arm of the study will receive financial incentives for attending their buprenorphine appointments and for being clean from other opioids. Participants in this group will also have up to two rides per week paid for to attend bup appointments.
Group II: Standard CareActive Control1 Intervention
Participants in this group will be treatment as usual and will not receive any incentives for attending their bup appointments or for being opioid abstinent.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Contingency management
2006
Completed Phase 4
~960

Find a Location

Who is running the clinical trial?

The Cooper Health SystemOTHER
76 Previous Clinical Trials
33,013 Total Patients Enrolled
Rowan UniversityLead Sponsor
23 Previous Clinical Trials
2,765 Total Patients Enrolled

Media Library

Contingency management Clinical Trial Eligibility Overview. Trial Name: NCT04585399 — N/A
Opioid Use Disorder Research Study Groups: Contingency Management, Standard Care
Opioid Use Disorder Clinical Trial 2023: Contingency management Highlights & Side Effects. Trial Name: NCT04585399 — N/A
Contingency management 2023 Treatment Timeline for Medical Study. Trial Name: NCT04585399 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any vacancies for subjects to join this research experiment?

"Affirmative. The information found on clinicaltrials.gov indicates that this trial is recruiting participants as of now. This experiment was first made available to the public on January 27th 2020 and has been edited most recently on November 23rd 2021. It requires a total of 100 volunteers from one medical site for completion."

Answered by AI

What is the overall enrollment for this clinical research project?

"Yes, according to clinicaltrials.gov, the trial is currently seeking participants with a post date of January 27th 2020 and an edit date of November 23rd 2021. 100 individuals will be enrolled across one site."

Answered by AI

What are the main aims of this medical experiment?

"This 3-month trial will measure patient Attendance at first scheduled clinic appointment as its primary outcome. Secondary endpoints include an evaluation of Opioid demand correlated with drug test results for opioid abstinence and buprenorphine adherence, a drawing task to assess Neurological Soft Signs associated with successful treatment, and Substance-free activities linked to urine tests measuring opioid abstention and buprenorphine compliance."

Answered by AI

Who else is applying?

What state do they live in?
Washington
How old are they?
18 - 65
What portion of applicants met pre-screening criteria?
Did not meet criteria
Recent research and studies
clinicaltrials.govStudy
Increasing MAT Engagement With Financial Incentives
2020. "Increasing MAT Engagement With Financial Incentives". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04585399.
All > Opioid Dependence
~4 spots leftby Jun 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top